Valvular & structural heart diseaseResearch article

Transcatheter Repair in Posterior, Anterior, and Bileaflet Mitral Valve Disease

JACC Cardiovasc IntervPublished

  • Pooled patient-level analysis of the EXPAND and EXPAND G4 studies

Authors' conclusion

Results from the EXPANDed studies demonstrate that subjects with DMR treated with M-TEER experienced significant improvements in outcomes, regardless of the location of prolapse or flail.

Study context

Population
Patients with degenerative mitral regurgitation (MR) undergoing mitral transcatheter edge-to-edge repair (M-TEER) with the MitraClip G3 or G4 systemof 2,205 in EXPANDed
Participants
556 patients
Comparison
Posterior vs anterior vs bileaflet degenerative mitral regurgitation (DMR) treated with M-TEER
  • Posteriorn = 389reference
  • Anteriorn = 106
  • Bileafletn = 61

Main finding

As reported in the abstract

30-day major adverse events · 30 days

Further findings

MR ≤1+ · 1 year

  • MR ≤1+: denominators 219, 57, 29

MR ≤1+ · 1 year

All groups showed a significant reduction in MR severity from baseline

Procedural outcomes

Low device and procedure times with high procedural success (discharge MR ≤2+) in all groups

Original publication

Transcatheter Repair in Posterior, Anterior, and Bileaflet Mitral Valve Disease. JACC Cardiovasc Interv. Published 5 March 2025. doi:10.1016/j.jcin.2024.12.023

Summarised from the published abstract; every number is checked against it